Trust Co. of Toledo NA OH Makes New Investment in Solventum Corporation $SOLV

Trust Co. of Toledo NA OH acquired a new position in shares of Solventum Corporation (NYSE:SOLVFree Report) during the second quarter, Holdings Channel reports. The institutional investor acquired 1,826 shares of the company’s stock, valued at approximately $138,000.

Several other institutional investors have also recently made changes to their positions in the company. Rossby Financial LCC acquired a new position in shares of Solventum in the 1st quarter valued at $25,000. Strengthening Families & Communities LLC increased its holdings in Solventum by 376.8% in the first quarter. Strengthening Families & Communities LLC now owns 329 shares of the company’s stock valued at $25,000 after buying an additional 260 shares in the last quarter. Barrett & Company Inc. raised its position in shares of Solventum by 206.2% in the second quarter. Barrett & Company Inc. now owns 398 shares of the company’s stock worth $30,000 after acquiring an additional 268 shares during the period. Hara Capital LLC purchased a new stake in shares of Solventum during the 1st quarter worth about $38,000. Finally, Smartleaf Asset Management LLC grew its position in shares of Solventum by 193.4% during the 1st quarter. Smartleaf Asset Management LLC now owns 534 shares of the company’s stock valued at $40,000 after acquiring an additional 352 shares during the period.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on SOLV shares. Argus raised Solventum from a “hold” rating to a “buy” rating and set a $90.00 price target for the company in a report on Tuesday, July 1st. Wells Fargo & Company boosted their price objective on Solventum from $79.00 to $82.00 and gave the company an “equal weight” rating in a research report on Monday, September 15th. UBS Group started coverage on Solventum in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $77.00 price objective for the company. Zacks Research upgraded Solventum from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 15th. Finally, Morgan Stanley raised shares of Solventum from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $80.00 to $103.00 in a report on Tuesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $84.89.

View Our Latest Analysis on Solventum

Solventum Price Performance

NYSE:SOLV opened at $70.53 on Monday. Solventum Corporation has a 12 month low of $60.70 and a 12 month high of $85.92. The stock has a 50 day moving average of $72.75 and a two-hundred day moving average of $72.08. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.14. The firm has a market cap of $12.23 billion, a P/E ratio of 32.65, a price-to-earnings-growth ratio of 2.87 and a beta of 0.50.

Solventum (NYSE:SOLVGet Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $1.69 EPS for the quarter, topping the consensus estimate of $1.45 by $0.24. Solventum had a return on equity of 29.93% and a net margin of 4.52%.The firm had revenue of $2.16 billion during the quarter, compared to analysts’ expectations of $2.12 billion. During the same period in the previous year, the business earned $1.56 earnings per share. The firm’s revenue for the quarter was up 3.8% on a year-over-year basis. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. On average, analysts expect that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

About Solventum

(Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

See Also

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Corporation (NYSE:SOLVFree Report).

Institutional Ownership by Quarter for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.